The Inflammasomes: Molecular Effectors of Host Resistance Against Bacterial, Viral, Parasitic, and Fungal Infections

Alexander Skeldon, Maya Saleh

Frontiers in Microbiology · 2011 · 58 citations · 142 references

DOIFull text

Open access

TL;DR

Inflammasomes are cytosolic PRR‑scaffolded complexes that activate caspase‑1 to process IL‑1β, IL‑18, and other substrates, driving inflammation and pyroptosis, and play a key role in host defense against diverse pathogens while pathogens counteract them. This review examines recent advances in inflammasome‑mediated recognition of bacterial, viral, parasitic, and fungal infections and their beneficial or detrimental effects on host resistance. The authors synthesize evidence on inflammasome activation pathways, caspase‑1–dependent cytokine maturation, and pyroptotic cell death in response to microbial and danger signals.

Abstract

The inflammasomes are large multi-protein complexes scaffolded by cytosolic pattern recognition receptors (PRRs) that form an important part of the innate immune system. They are activated following the recognition of microbial-associated molecular patterns (MAMPs) or host-derived danger signals (danger-associated molecular patterns or DAMPs) by PRRs. This recognition results in the recruitment and activation of the pro-inflammatory protease caspase-1, which cleaves its preferred substrates pro-interleukin-1β (IL-1β) and pro-IL-18 into their mature biologically active cytokine forms. Through processing of a number of other cellular substrates, caspase-1 is also required for the release of "alarmins" and the induction and execution of an inflammatory form of cell death termed pyroptosis. A growing spectrum of inflammasomes have been identified in the host defence against a variety of pathogens. Reciprocally, pathogens have evolved effector strategies to antagonize the inflammasome pathway. In this review we discuss recent developments in the understanding of inflammasome-mediated recognition of bacterial, viral, parasitic and fungal infections and the beneficial or detrimental effects of inflammasome signalling in host resistance.

References

142